Biotechnology

VaxGen, Inc. , a biopharmaceutical company, today provided guidance on its expected monthly cash expenditures following the most recent restructuring undertaken on April 9, 2008. VaxGen expects that its average monthly cash expenditures going forward are

Theratechnologies advises of an upcoming conference call and webcast to discuss the signing of a strategic agreement to explore the use of tesamorelin in an additional indication. The call will be moderated by Dr. Andrea Gilpin, Executive Director, IR &a

Theratechnologies souhaite annoncer la tenue d'une conférence téléphonique et d'une webdiffusion afin de discuter d'une entente stratégique visant à évaluer l'utilisation de la tésamoréline dans une indication additionnelle. La conférence sera d

Theratechnologies advises of an upcoming conference call and webcast to discuss the signing of a strategic agreement to explore the use of tesamorelin in an additional indication. The call will be moderated by Dr. Andrea Gilpin, Executive Director, IR &a

China Biologic Products, Inc. , one of the leading plasma-based pharmaceutical companies inthe People's Republic of China , today announced that it will conduct a conference call at 5:00 p.m. Eastern Time on Thursday, May 15, 2008 to discuss the first qu

MEDdevice Acquisition Co., LLC MDAC is proud to announce that it has engaged a highly experienced team with deep domain experience and proven success optimizing investments in the medical device market as board members and advisors.

Pharmos Corporation announced today that its President and Chief Financial Officer, S. Colin Neill, will present at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19, 2008 at 5:15 PM Central Europe Daylight Time . The con

Sigma-Aldrich announced today that Chief Administrative Officer and Chief Financial Officer Michael R. Hogan will retire at a date to be determined this summer. Hogan, who turned 55 in April, had notified the Company early this year of his desire to reti